Macrophage VLDLR mediates obesity-induced insulin resistance with adipose tissue inflammation

[1]  K. Schramm,et al.  Alternatively activated macrophages do not synthesize catecholamines or contribute to adipose tissue adaptive thermogenesis , 2017, Nature Medicine.

[2]  A. Saghatelian,et al.  SREBP1 Contributes to Resolution of Pro-inflammatory TLR4 Signaling by Reprogramming Fatty Acid Metabolism. , 2017, Cell metabolism.

[3]  P. Meikle,et al.  Adipocyte Ceramides Regulate Subcutaneous Adipose Browning, Inflammation, and Metabolism. , 2016, Cell metabolism.

[4]  K. Clément,et al.  Circulating Blood Monocyte Subclasses and Lipid-Laden Adipose Tissue Macrophages in Human Obesity , 2016, PloS one.

[5]  Ji‐Won Kim,et al.  Glucose-6-Phosphate Dehydrogenase Deficiency Improves Insulin Resistance With Reduced Adipose Tissue Inflammation in Obesity , 2016, Diabetes.

[6]  A. Ferrante,et al.  Autophagy Is Dispensable for Macrophage-Mediated Lipid Homeostasis in Adipose Tissue , 2016, Diabetes.

[7]  M. Hoch,et al.  Ceramide Synthase 5 Is Essential to Maintain C16:0-Ceramide Pools and Contributes to the Development of Diet-induced Obesity* , 2016, The Journal of Biological Chemistry.

[8]  M. Jeschke,et al.  Palmitate differentially regulates the polarization of differentiating and differentiated macrophages , 2016, Immunology.

[9]  S. Summers,et al.  Ceramides – Lipotoxic Inducers of Metabolic Disorders , 2015, Trends in Endocrinology & Metabolism.

[10]  D. Rader,et al.  Microsomal Triglyceride Transfer Protein Transfers and Determines Plasma Concentrations of Ceramide and Sphingomyelin but Not Glycosylceramide* , 2015, The Journal of Biological Chemistry.

[11]  J. McDonald,et al.  Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis. , 2015, Cell metabolism.

[12]  A. Xu,et al.  Adiponectin Enhances Cold-Induced Browning of Subcutaneous Adipose Tissue via Promoting M2 Macrophage Proliferation. , 2015, Cell metabolism.

[13]  Matthias Blüher,et al.  Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. , 2014, Cell metabolism.

[14]  Jessica L. Cohen,et al.  Lipid storage by adipose tissue macrophages regulates systemic glucose tolerance. , 2014, American journal of physiology. Endocrinology and metabolism.

[15]  R. Palmiter,et al.  Eosinophils and Type 2 Cytokine Signaling in Macrophages Orchestrate Development of Functional Beige Fat , 2014, Cell.

[16]  B. Spiegelman,et al.  Meteorin-like Is a Hormone that Regulates Immune-Adipose Interactions to Increase Beige Fat Thermogenesis , 2014, Cell.

[17]  J. Eilers,et al.  Local proliferation of macrophages in adipose tissue during obesity-induced inflammation , 2014, Diabetologia.

[18]  H. Tao,et al.  Very Low Density Lipoprotein Receptor (VLDLR) Expression Is a Determinant Factor in Adipose Tissue Inflammation and Adipocyte-Macrophage Interaction* , 2013, The Journal of Biological Chemistry.

[19]  P. Scherer,et al.  An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. , 2013, Cell metabolism.

[20]  Dorothy D. Sears,et al.  Macrophage Glucose-6-Phosphate Dehydrogenase Stimulates Proinflammatory Responses with Oxidative Stress , 2013, Molecular and Cellular Biology.

[21]  J. Seong,et al.  Endoplasmic reticulum stress induces hepatic steatosis via increased expression of the hepatic very low‐density lipoprotein receptor , 2013, Hepatology.

[22]  H. Shapiro,et al.  Adipose tissue foam cells are present in human obesity. , 2013, The Journal of clinical endocrinology and metabolism.

[23]  D. Ory,et al.  Palmitate and Lipopolysaccharide Trigger Synergistic Ceramide Production in Primary Macrophages* , 2012, The Journal of Biological Chemistry.

[24]  Y. Igarashi,et al.  Ceramide kinase deficiency improves diet‐induced obesity and insulin resistance , 2012, FEBS letters.

[25]  Alberto Mantovani,et al.  Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.

[26]  T. Hornemann,et al.  C16 ceramide is crucial for triacylglycerol-induced apoptosis in macrophages , 2012, Cell Death and Disease.

[27]  R. Schwendener,et al.  Inflammation Is Necessary for Long-Term but Not Short-Term High-Fat Diet–Induced Insulin Resistance , 2011, Diabetes.

[28]  R. Eckel.  The complex metabolic mechanisms relating obesity to hypertriglyceridemia. , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[29]  J. Borén,et al.  The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction. , 2011, The Journal of clinical investigation.

[30]  D. Clegg,et al.  Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. , 2011, The Journal of clinical investigation.

[31]  David Montaner,et al.  Differential Lipid Partitioning Between Adipocytes and Tissue Macrophages Modulates Macrophage Lipotoxicity and M2/M1 Polarization in Obese Mice , 2011, Diabetes.

[32]  S. Shoelson,et al.  Type 2 diabetes as an inflammatory disease , 2011, Nature Reviews Immunology.

[33]  Isao Usui,et al.  Regulatory Mechanisms for Adipose Tissue M1 and M2 Macrophages in Diet-Induced Obese Mice , 2009, Diabetes.

[34]  Robert A. Hegele,et al.  Plasma lipoproteins: genetic influences and clinical implications , 2009, Nature Reviews Genetics.

[35]  J. Olefsky,et al.  Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. , 2008, Cell Metabolism.

[36]  S. Summers,et al.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. , 2008, Endocrine reviews.

[37]  I. Charo.  Macrophage Polarization and Insulin Resistance: PPARγ in Control , 2007 .

[38]  Frank Brombacher,et al.  Macrophage-specific PPARγ controls alternative activation and improves insulin resistance , 2007, Nature.

[39]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[40]  A. Saltiel,et al.  Increased Inflammatory Properties of Adipose Tissue Macrophages Recruited During Diet-Induced Obesity , 2007, Diabetes.

[41]  A. Goldfine,et al.  Inflammation and insulin resistance. , 2006, The Journal of clinical investigation.

[42]  V. Saraswathi,et al.  The role of lipolysis in mediating the proinflammatory effects of very low density lipoproteins in mouse peritoneal macrophages Published, JLR Papers in Press, April 25, 2006. , 2006, Journal of Lipid Research.

[43]  R. Kitazawa,et al.  MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.

[44]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[45]  K. V. van Dijk,et al.  Role of the macrophage very-low-density lipoprotein receptor in atherosclerotic lesion development. , 2005, Atherosclerosis.

[46]  L. Zitvogel,et al.  In vivo veritas , 2005, Nature Biotechnology.

[47]  E. Wirrell,et al.  Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification. , 2005, American journal of human genetics.

[48]  B. Teusink,et al.  The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.M400009-JLR200 , 2004, Journal of Lipid Research.

[49]  J. Brunzell,et al.  Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. , 2004, The Journal of clinical endocrinology and metabolism.

[50]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[51]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[52]  I. Miyamori,et al.  The very low density lipoprotein (VLDL) receptor – a peripheral lipoprotein receptor for remnant lipoproteins into fatty acid active tissues , 2003, Molecular and Cellular Biochemistry.

[53]  Michael Karin,et al.  A central role for JNK in obesity and insulin resistance , 2002, Nature.

[54]  P. Scherer,et al.  ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism , 2002, Trends in Endocrinology & Metabolism.

[55]  K. V. van Dijk,et al.  Protection From Obesity in Mice Lacking the VLDL Receptor , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[56]  Y. Terauchi,et al.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.

[57]  A. Merrill.  Characterization of serine palmitoyltransferase activity in Chinese hamster ovary cells. , 1983, Biochimica et biophysica acta.

[58]  M. Brown,et al.  Receptor-mediated endocytosis: insights from the lipoprotein receptor system. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[59]  S. Summers,et al.  CerS2 Haploinsufficiency Inhibits β-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance. , 2014, Cell metabolism.

[60]  J. Rutledge,et al.  Postprandial VLDL lipolysis products increase monocyte adhesion and lipid droplet formation via activation of ERK2 and NFκB. , 2014, American journal of physiology. Heart and circulatory physiology.

[61]  정지형.  Arginase I and the very low-density lipoprotein receptor are associated with phenotypic biomarkers for obesity , 2012 .

[62]  I. Charo.  Macrophage polarization and insulin resistance: PPARgamma in control. , 2007, Cell metabolism.

[63]  H. Ginsberg,et al.  Diabetic dyslipidemia. , 2006, Endocrinology and metabolism clinics of North America.

[64]  S. Summers,et al.  Ceramides in insulin resistance and lipotoxicity. , 2006, Progress in lipid research.

[65]  I. Miyamori,et al.  The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor. , 2004, Journal of atherosclerosis and thrombosis.

[66]  M. Taskinen.  Diabetic dyslipidemia. , 2002, Atherosclerosis. Supplements.

[67]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.